American Portfolios Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

American Portfolios Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$7.29K	Hold	3,440	–	–	﹤0.01%	2654
2022 Q2	$9.25K	Hold	3,440	–	–	﹤0.01%	2599
2022 Q1	$14.9K	Hold	3,440	–	–	﹤0.01%	2508
2021 Q4	$17.8K	Hold	3,440	–	–	﹤0.01%	2383
2021 Q3	$21.1K	Hold	3,440	–	–	﹤0.01%	2265
2021 Q2	$34.7K	Hold	3,440	–	–	﹤0.01%	1923
2021 Q1	$47.4K	Buy	+3,440	New	+$47.7K	﹤0.01%	1632

Other funds holding NAUT

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

American Portfolios Advisors's NAUT Position: Q3 2022 in Review

American Portfolios Advisors held its Nautilus Biotechnolgy (NAUT) position steady in Q3 2022 at 3,440 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

American Portfolios Advisors first reported a position in NAUT in Q1 2021 and has held it in 7 quarters since. The position peaked at $47.4K in Q1 2021. 86 funds tracked by Wall St. Rank hold NAUT as of Q3 2022.

American Portfolios Advisors held 3,440 shares of Nautilus Biotechnolgy worth $7.29K as of Q3 2022.
American Portfolios Advisors left its Nautilus Biotechnolgy share count unchanged in Q3 2022.
Nautilus Biotechnolgy made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2654 holding.
American Portfolios Advisors first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 7 quarters since.
American Portfolios Advisors's Nautilus Biotechnolgy position peaked at $47.4K in Q1 2021.
86 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.